Compare Arko Corp. (ARKO) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arko Corp. vs Novartis AG — how do they compare? Arko Corp. trades at $4.33 (market cap $493.06M), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 599.1× Arko Corp.'s market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| ARKO | NVS | |
|---|---|---|
Market Cap | $493.06M | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $8.64 | $168.62 |
52-Week Low | $3.82 | $119.31 |
Enterprise Value | $2.67B | $336.69B |
Dividend Yield | 2.73% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arko Corp.
ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
Read more on ARKO →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
